Literature DB >> 16365690

A multicenter study of patients with adult-onset Still's disease compared with systemic juvenile idiopathic arthritis.

Salih Pay1, Nuran Türkçapar, Mukaddes Kalyoncu, Ismail Simşek, Esin Beyan, Ihsan Ertenli, M Akif Oztürk, Nurşen Düzgün, Hakan Erdem, Zeynep Ozbalkan, Sedat Kiraz, Gülay Kinikli, Nesrin Besbas, Ayhan Dinç, Aşkin Ateş, Umit Olmez, Meral Calgüneri, Olcay Tiryaki Aydintuğ, Ayşin Bakkaloğlu, Mustafa Turan, Murat Turgay, Yaşar Karaaslan, Rezzan Topaloğlu, Murat Duman, Seza Ozen.   

Abstract

Adult-onset Still's disease (AOSD) has often been regarded as the adult spectrum of systemic juvenile idiopathic arthritis (sJIA). The present study aims to compare the clinical and laboratory features, the disease course and the response to treatment in patients having AOSD with those having sJIA. Retrospective review of all available data that were filled out by adult and paediatric rheumatologists from six centers using a standard data extraction form was performed. A total of 95 patients with AOSD and 25 patients with sJIA were recruited for the study. The frequency of fever, rash, myalgia, weight loss and sore throat was higher in patients with AOSD. The pattern of joint involvement differed slightly. Laboratory findings were similar in both groups, except that liver dysfunction and neutrophilia were more common among adults. A multiphasic pattern dominated the childhood cases, whereas the most frequent course was a chronic one in adults. Corticosteroids and methotrexate were the most commonly employed therapy; however, chloroquine was another popular therapy in the adult group. We showed a difference in the rate of clinical and laboratory features between patients with AOSD and those with sJIA. AOSD and sJIA may still be the same disease, and children may simply be reacting differently as the result of the first encounter of the putative antigens with the immune system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16365690     DOI: 10.1007/s10067-005-0138-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  21 in total

1.  Different articular outcomes of Still's disease in Chinese children and adults.

Authors:  S J Lin; H C Chao; D C Yan
Journal:  Clin Rheumatol       Date:  2000       Impact factor: 2.980

2.  Treatment of adult-onset Still's disease with leflunomide and chloroquine combination in two patients.

Authors:  T Pirildar
Journal:  Clin Rheumatol       Date:  2003-05       Impact factor: 2.980

3.  Amyloidosis of juvenile chronic arthritis in Turkish children.

Authors:  N Besbas; U Saatci; A Bakkaloglu; S Ozen
Journal:  Scand J Rheumatol       Date:  1992       Impact factor: 3.641

4.  Preliminary criteria for classification of adult Still's disease.

Authors:  M Yamaguchi; A Ohta; T Tsunematsu; R Kasukawa; Y Mizushima; H Kashiwagi; S Kashiwazaki; K Tanimoto; Y Matsumoto; T Ota
Journal:  J Rheumatol       Date:  1992-03       Impact factor: 4.666

5.  Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997.

Authors:  R E Petty; T R Southwood; J Baum; E Bhettay; D N Glass; P Manners; J Maldonado-Cocco; M Suarez-Almazor; J Orozco-Alcala; A M Prieur
Journal:  J Rheumatol       Date:  1998-10       Impact factor: 4.666

6.  Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.

Authors:  Pierre Quartier; Pierre Taupin; Franck Bourdeaut; Irène Lemelle; Pascal Pillet; Michel Bost; Jean Sibilia; Isabelle Koné-Paut; Sylvie Gandon-Laloum; Marc LeBideau; Brigitte Bader-Meunier; Richard Mouy; Marianne Debré; Paul Landais; Anne-Marie Prieur
Journal:  Arthritis Rheum       Date:  2003-04

7.  Infliximab in the treatment of adult Still's disease refractory to conventional therapy.

Authors:  L Cavagna; R Caporali; O Epis; F Bobbio-Pallavicini; C Montecucco
Journal:  Clin Exp Rheumatol       Date:  2001 May-Jun       Impact factor: 4.473

8.  Still's disease in the adult.

Authors:  E G Bywaters
Journal:  Ann Rheum Dis       Date:  1971-03       Impact factor: 19.103

9.  Adult onset Still's disease in northern India: comparison with juvenile onset Still's disease.

Authors:  S S Uppal; I R Pande; A Kumar; S Kailash; N G Sekharan; C M Adya; A N Malaviya
Journal:  Br J Rheumatol       Date:  1995-05

10.  Still's disease in children and adults: a distinct pattern of acute-phase proteins.

Authors:  M Sobieska; K Fassbender; A Aeschlimann; P Bourgeois; S Mackiewicz; W Müller
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

View more
  38 in total

1.  Therapeutic responses and prognosis in adult-onset Still's disease.

Authors:  Hyoun-Ah Kim; Jun-Mo Sung; Chang-Hee Suh
Journal:  Rheumatol Int       Date:  2011-01-29       Impact factor: 2.631

2.  Cyclosporine in Resistant Systemic Arthritis - A Cheaper Alternative to Biologics.

Authors:  Priyankar Pal; Prabhas Prasun Giri; Rajiv Sinha
Journal:  Indian J Pediatr       Date:  2019-04-01       Impact factor: 1.967

3.  [Adult onset Still's disease].

Authors:  B Manger
Journal:  Z Rheumatol       Date:  2008-09       Impact factor: 1.372

Review 4.  Autoinflammation: From monogenic syndromes to common skin diseases.

Authors:  Tien V Nguyen; Edward W Cowen; Kieron S Leslie
Journal:  J Am Acad Dermatol       Date:  2013-02-28       Impact factor: 11.527

5.  Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome.

Authors:  Eric S Weiss; Charlotte Girard-Guyonvarc'h; Dirk Holzinger; Adriana A de Jesus; Zeshan Tariq; Jennifer Picarsic; Eduardo J Schiffrin; Dirk Foell; Alexei A Grom; Sandra Ammann; Stephan Ehl; Tomoaki Hoshino; Raphaela Goldbach-Mansky; Cem Gabay; Scott W Canna
Journal:  Blood       Date:  2018-01-11       Impact factor: 22.113

Review 6.  Pathogenesis of adult-onset Still's disease: new insights from the juvenile counterpart.

Authors:  Yvan Jamilloux; Mathieu Gerfaud-Valentin; Fabio Martinon; Alexandre Belot; Thomas Henry; Pascal Sève
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

Review 7.  2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications.

Authors:  Sarah Ringold; Pamela F Weiss; Timothy Beukelman; Esi Morgan Dewitt; Norman T Ilowite; Yukiko Kimura; Ronald M Laxer; Daniel J Lovell; Peter A Nigrovic; Angela Byun Robinson; Richard K Vehe
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-10       Impact factor: 4.794

8.  2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications.

Authors:  Sarah Ringold; Pamela F Weiss; Timothy Beukelman; Esi Morgan DeWitt; Norman T Ilowite; Yukiko Kimura; Ronald M Laxer; Daniel J Lovell; Peter A Nigrovic; Angela Byun Robinson; Richard K Vehe
Journal:  Arthritis Rheum       Date:  2013-10

Review 9.  Molecular genetic analysis for periodic fever syndromes: a supplemental role for the diagnosis of adult-onset Still's disease.

Authors:  Hongbin Li; Irina Abramova; Sandra Chesoni; Qingping Yao
Journal:  Clin Rheumatol       Date:  2018-06-17       Impact factor: 2.980

10.  Epidemiological study of adult-onset Still's disease using a Japanese administrative database.

Authors:  Nobuo Sakata; Sayuri Shimizu; Fumio Hirano; Kiyohide Fushimi
Journal:  Rheumatol Int       Date:  2016-08-09       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.